MedTrace Logo

Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada

NCT02705833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 591

Last updated 2017-04-24

No results posted yet for this study

Summary

The primary objective of the study is to characterize the medical management of squamous cell carcinoma head and neck (SCCHN) patients diagnosed with recurrent/metastatic (R/M) disease (between 01July2013 and 30 June 2014) in the real-world setting.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-12-06
Completion
2016-12-06

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02705833 on ClinicalTrials.gov